Loading...

ATHA ATHIRA PHARMA INC Management Changes 8-K Filing

THR

TH

ATHIRA PHARMA INC

(ATHA)

2024 8-K

Show Summary

Show Summary

Reverse Stock Splits

Financial Statements

Stock Listing Transfer

Financial Results

Financial Results

Nasdaq Compliance Notice

Executive Changes

Workforce Reduction

Clinical Trial Results

Earnings Report

Annual Meeting Results

Settlement Approval

Financial Results

Financial Results and Induc...

Financial Condition Announc...

Earnings Reports

Earnings Reports

Management Change

Earnings Reports

Financial Results Announcement

Equity Offering

External Links:

Athira Pharma announced the termination of two executives, Andrew Gengos and Rachel Lenington, with severance payments of $363,750 and $375,000 respectively, and retention incentives for current executives including stock options and restricted stock

AI Assistant

ATHIRA PHARMA INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.